Contraindications for TPA Administration

  • General Contraindications

    • Risk of causing a bleed is higher than the possibility of dissolving a clot.

    • TPA is contraindicated if the time since onset of symptoms is longer than four and a half hours.

    • If the exact time of symptom onset is unknown, supportive therapy is preferred to weigh the risks and benefits of TPA use.

  • Specific Contraindications

    • INR Threshold

    • TPA is contraindicated for patients with an INR (International Normalized Ratio) greater than 1.7.

    • Patients on anticoagulation therapy with elevated INR are at a significant risk for bleeding, making TPA unsafe.

    • Recent Head Trauma

    • Contraindicated in patients who have experienced a stroke or major head injury within the past three months.

TPA Administration and Protocols

  • Weight-based Calculation

    • TPA doses are calculated based on patient weight, although exact calculations are rarely tested on exams.

  • IV Requirements

    • A minimum of two IV sites is required for TPA administration:

    • One for TPA infusion.

    • One for fluids.

    • More than two IV sites are encouraged if possible.

  • Infusion Protocol

    • Ten percent of the TPA dose must be administered within the first minute.

    • The remaining ninety percent of the dose is given over one hour.

  • Monitoring During Administration

    • Continuous monitoring of vital signs, including blood pressure, is essential.

    • Frequent neurological checks during TPA infusion:

    • Every 15 minutes during the infusion.

    • Every 30 minutes for the first 6 hours post-infusion.

    • Every hour for 24 hours after infusion.

  • Blood Pressure Management

    • Maintain blood pressure below $185/110$ mmHg during TPA infusion to ensure adequate perfusion to the brain.

    • Higher blood pressure is necessary to allow blood flow past the clot for adequate brain perfusion.

Case Example

  • Patient Case

    • Described a patient who experienced a severe headache and loss of peripheral vision.

    • High blood pressure was a factor, resulting from not taking medication and consuming alcohol, which thinned the blood.

Post-Stroke Management

  • Transitional Care Focus

    • Management of self-care deficits, especially swallowing and prevention of aspiration.

    • Education regarding dietary modifications, such as pureed foods and thickened liquids.

    • Communication strategies for addressing confusion.

  • Positioning Recommendations

    • Position the head of the bed elevated between 30 to 45 degrees to prevent aspiration.

  • Early Intervention Techniques

    • Focus on proper hand positioning and limb mobility to preserve function.

Types of Stroke: Hemorrhagic vs. Ischemic

  • Intracerebral Hemorrhage

    • Major cause is spontaneous rupture of small vessels due to uncontrolled hypertension.

    • More common in older adults.

    • Other causes include:

    • AVMs (arteriovenous malformations).

    • Trauma, brain tumors, certain illicit drugs.

  • Subarachnoid Hemorrhage

    • Defined as bleeding into the space between the brain and skull.

    • Causes include:

    • Ruptured aneurysms.

    • Congenital AVMs.

    • Trauma and hypertension.

    • Complications include increased intracranial pressure (ICP), loss of consciousness (LOC), and vasospasms.

Aneurysms

  • Aneurysms involve weakening and ballooning of artery walls, often due to:

    • Atherosclerosis, hypertension, congenital defects, trauma, and aging.

    • Hemorrhagic strokes can lead to:

    • Compression of brain tissue.

    • Increased ICP and secondary ischemia.

Arteriovenous Malformations (AVMs)

  • Congenital blood vessel abnormalities characterized by a tangle of arteries and veins without a capillary bed.

    • Can lead to hemorrhagic strokes if ruptured.

    • Patients often unaware of these malformations until stroke symptoms occur.

Signs and Symptoms of AVMs

  • If the patient is conscious:

    • Severe and sudden headache.

    • Nausea and vomiting due to increased ICP.

    • Changes in LOC and possible seizures.

Initial Assessment for Stroke

  • Use NIH Stroke Scale assessments and non-contrast CT to differentiate between ischemic and hemorrhagic strokes.

  • After determining stroke type, cerebral angiography may be performed to identify possible aneurysms or AVMs.

Management of Hemorrhagic Stroke

  • Limited interventions focus predominantly on support.

  • Emphasis on prevention of complications such as rebleeding and addressing increases in ICP early on.

Complications of Hemorrhagic Stroke

  • Vasospasms

    • Characterized by narrowing of cerebral arteries, especially after subarachnoid hemorrhages.

    • Peak risk occurs between three and fourteen days post-hemorrhage.

    • Signs include worsened headache, decreased LOC, and new neurological deficits.

    • New deficits indicate possible vasospasm.

  • Medical Management for Vasospasms

    • Calcium channel blocker: Nimodipine (n-i-m-o-d-i-p-i-n).

    • Surgical interventions to clip aneurysms or AVMs can prevent further bleeding and complications.